As PhD students near the end of their programs, they often consider whether to pursue a postdoc or explore entrepreneurship opportunities based on their research advancements.

There's increasing acceptance of transitioning from academia to industry, as innovations often stem from academic research, and pursuing entrepreneurship can be a viable path for scientists. Most drugs on the market originate from discoveries made in academia, which are then commercialized by biotech or pharmaceutical companies.

There's a growing trend of scientists moving into startups, as entrepreneurship has become a viable career path, supported by infrastructure like Y Combinator and AWS.

Providing a path for PhD students and postdocs to become entrepreneurs can leverage their deep knowledge of scientific discoveries for company success.

Many PhD students and postdocs lack exposure to entrepreneurship, leading to misconceptions about funding and company formation.

After college, I worked at a biotech firm but felt the slow career progression pushed me to pursue entrepreneurship, especially after a roommate suggested we start a company together.

Many college students are dropping out to pursue AI startups because they see it as a unique opportunity that may not come again.

Entrepreneurs are often seen as risk-takers, but it's crucial to make coherent bets on risks, as significant opportunities come with associated risks.

In academia, most intellectual property is owned by universities, which complicates the process for researchers wanting to commercialize their discoveries.